An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

A. Jackson, Lisa; J. Anderson, Evan; Rouphael, Nadine; C. Roberts, Paul; Makhene, Mamodikoe; N. Coler, Rhea; Paine McCullough, Michele; D. Chappell, James; R. Denison, Mark; J. Stevens, Laura; J. Pruijssers, Andrea; B. McDermott, Adrian; Flach, Britta; A. Doria‐Rose, Nicole; S. Corbett, Kizzmekia; M. Morabito, Kaitlyn; O’Dell, Sijy; D. Schmidt, Stephen; A. Swanson, Phillip; Padilla, Marcelino; R. Mascola, John; M. Neuzil, Kathleen; Bennett, Hamilton; Sun, Wellington; Peters, Etza; Makowski, Mat; Albert, Jim; Cross, Kaitlyn; Buchanan, Wendy; Pikaart-Tautges, Rhonda; E. Ledgerwood, Julie; S. Graham, Barney; H. Beigel, John

doi:10.1056/nejmoa2022483

Public

An mRNA Vaccine against SARS-CoV-2 — Preliminary Report

Published in New England Journal of Medicine • Jul 14, 2020

Authors:

Lisa A. Jackson

Evan J. Anderson

Nadine Rouphael

Abstract

BACKGROUND: The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine. The candidate vaccine mRNA-1273 encodes the stabilized prefusion SARS-CoV-2 spike protein. METHODS: We cond...

Subject

Virology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Coronavirus disease 2019 (COVID-19)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!